Researchers used EEG to study high-dose inhaled 5-MeO-DMT in humans. Unlike other psychedelics, the drug reduced brain ...
Verywell Health on MSN
DMT treatment options for multiple sclerosis
Gilenya and Tascenso ODT are approved to treat relapsing forms of multiple sclerosis (MS) in adults. Gilenya and Tascenso ODT ...
PsyPost on MSN
Intranasal 5-MeO-DMT effects peak within 15 minutes and lack strong visuals, study finds
A study examining subjective experiences after intranasal application of 5-MeO-DMT found that its effects peak 8-15 minutes ...
A Canadian-based pharmaceutical company has received approval to conduct a clinical study of the psychedelic compound DMT as a treatment for stroke. Under the plan, pharmaceutical development company ...
In April, Imperial College London launched the Centre for Psychedelic Research, a first-of-its-kind facility focused on the study of mind-altering substances. While much of that research has centered ...
Known as the “spirit molecule” to psychedelics enthusiasts, N,N-Dimethyltryptamine (DMT) is said to produce vivid and strangely similar hallucinations for many who take it. Now, a new extended-state ...
When news breaks, you need to understand what actually matters. At Vox, our mission is to help you make sense of the world — and that work has never been more vital. But we can’t do it on our own. We ...
A new study from Imperial College London has found significant overlap between the experiences reported by subjects who have had near-death experiences, and volunteers administered with a powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback